Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award

Published on by Health Scientists

Prof. Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award 

Former Vice Chancellor | Utkal University | India

Prof. (Dr.) Pradeep Kumar Chand is a distinguished academician and researcher, currently serving as Chairperson of NAAC Peer Teams constituted by the National Assessment and Accreditation Council (Government of India) and formerly the Vice Chancellor of a State University. He earned his B.Sc. (Botany Hons.) and M.Sc. (Botany) with top distinctions and obtained his Ph.D. in Science from a reputed university in the United Kingdom, specializing in Plant Biotechnology and Genetic Engineering. With over 37 years of teaching and research experience, Prof. Chand’s pioneering contributions encompass plant tissue culture, genetic transformation, somatic hybridization, DNA fingerprinting, biogenic nanotechnology, and phytochemical analysis. He has guided numerous postgraduate research scholars, including several Ph.D. and M.Phil. awardees, and has authored numerous research papers in reputed international and national journals. His work in green nanotechnology and nano-onco-therapeutics has earned wide academic recognition. Prof. Chand has been honored with prestigious fellowships from organizations such as the DBT, DST, and INSA, and has served as a Biotechnology Overseas Associate under the Government of India’s Department of Biotechnology. His research collaborations with globally recognized institutions in Europe, Asia, and the United States highlight his international scientific engagement. Additionally, Prof. Chand has held editorial and peer-review roles in several scientific journals, contributing significantly to advancing research standards in biotechnology and plant sciences both nationally and internationally. He has 2333 citations from 81 documents with an h-index of 27.

Profiles: Google Scholar | Scopus

Publications

1. Genetically transformed root extracts of medicinal plant Sida acuta Burm.f. attenuate hyperglycemic effects in induced diabetic rats. (2025). Plant Cell, Tissue and Organ Culture.

2. Validation of PCR amplicon-based directed amplified minisatellite DNA (DAMD) markers for analysis of population structure and fruit trait association of promising Indian mangoes. (2025). Genetic Resources and Crop Evolution.

3. Hexavalent chromium bioaccumulation mediated enhancement of pyrethrin production in African marigold (Tagetes erecta L.): a promising plant for phytoremediation. (2023). Acta Physiologiae Plantarum.

4. Silver nanocrystals bio-fabricated using Rhizobium rhizogenes-transformed in vitro root extracts demonstrate health proactive properties. (2022). Bionanoscience.

5. Anthropogenic interventions regulate forest structure and carbon stock in transitional dry forests of Similipal Biosphere Reserve, India. (2022). Ecoscience.

Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).